David Scadden
Director · 2 filings · Latest: Jun 18, 2026
AGIOS PHARMACEUTICALS, INC.
Editas Medicine, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AGIO | David Scadden | Director | Jun 18, 2026 | Option Exercise | $0.00 | 2,816 | — | 20,419 | |
AGIO | DAVID SCADDEN | — | Oct 8, 2025 | Proposed Sale | $41.00 | 200 | $8.2K | — | |
AGIO | DAVID SCADDEN | — | Sep 30, 2025 | Proposed Sale | $40.00 | 200 | $8.0K | — | |
AGIO | DAVID T. SCADDEN | — | Aug 27, 2025 | Proposed Sale | $40.00 | 200 | $8.0K | — | |
AGIO | DAVID SCADDEN | — | Jul 10, 2025 | Proposed Sale | $40.00 | 1,400 | $56.0K | — |